[HTML] mdpi.com

[HTML][HTML] Resistance to molecularly targeted therapies in melanoma

M Patel, A Eckburg, S Gantiwala, Z Hart, J Dein, K Lam… - Cancers, 2021 - mdpi.com
Simple Summary Metastatic melanoma has poor survival rates in comparison to other types
of skin cancer. Traditional therapies are not very effective in treating advanced melanoma …
被引用次数：47 相关文章
[HTML] nih.gov

[HTML][HTML] Resistance to Molecularly Targeted Therapies in Melanoma

M Patel, A Eckburg, S Gantiwala, Z Hart, J Dein, K Lam… - Cancers, 2021 - ncbi.nlm.nih.gov
Malignant melanoma is the most aggressive type of skin cancer with invasive growth
patterns. In 2021, 106,110 patients are projected to be diagnosed with melanoma, out of …

Resistance to Molecularly Targeted Therapies in Melanoma.

M Patel, A Eckburg, S Gantiwala, Z Hart, J Dein… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Metastatic melanoma has poor survival rates in comparison to
other types of skin cancer. Traditional therapies are not very effective in treating advanced …

Resistance to Molecularly Targeted Therapies in Melanoma.

M Patel, A Eckburg, S Gantiwala, Z Hart, J Dein, K Lam… - Cancers, 2021 - europepmc.org
Malignant melanoma is the most aggressive type of skin cancer with invasive growth
patterns. In 2021, 106,110 patients are projected to be diagnosed with melanoma, out of …

Resistance to Molecularly Targeted Therapies in Melanoma

M Patel, A Eckburg, S Gantiwala, Z Hart, J Dein… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Malignant melanoma is the most aggressive type of skin cancer with invasive growth
patterns. In 2021, 106,110 patients are projected to be diagnosed with melanoma, out of …

Resistance to Molecularly Targeted Therapies in Melanoma.

M Patel, A Eckburg, S Gantiwala, Z Hart, J Dein, K Lam… - Cancers, 2021 - europepmc.org
Malignant melanoma is the most aggressive type of skin cancer with invasive growth
patterns. In 2021, 106,110 patients are projected to be diagnosed with melanoma, out of …